Endo Health Solutions

NASDAQ: ENDP

ENDP Articles

March 15, 2016: Here are four stocks trading with heavy volume among 33 equities making new 52-week lows in Tuesday’s session. Valeant Pharmaceuticals International Inc. (NYSE: VRX) dropped by more...
March 10, 2016: Here are four stocks trading with heavy volume among 45 equities making new 52-week lows in Thursday’s session. J2 Global Inc. (NASDAQ: JCOM) posted a new 52-week low on Thursday....
February 29, 2016: Here are four stocks trading with heavy volume among 30 equities making new 52-week lows today. Endo International plc (NASDAQ: ENDP) dropped about 22% on Monday to post a new...
Thursday's top analyst calls include General Electric, 3M, Shopify, SunPower, Zafgen, CIT, Ericsson, Honeywell.
These specialty pharmaceutical stocks have tremendous upside potential for 2016 and could be offering investors outstanding entry points at current trading levels.
The RBC U.S. Equity Top Picks list has handily outperformed the S&P 500 this year and since inception.
Monday's top analyst upgrades, downgrades and initiations include Best Buy, CA, Deere, Eli Lilly, Ferrari, Netflix, Oracle and Salesforce.com.
Some stocks have had a tough quarter and continued to struggle through October. These are the month's 10 worst-performing S&P 500 stocks.
Last week, a few biotech companies made absolutely massive runs, and some had serious falls.
With specialty pharmaceutical stocks having the chance to move dramatically higher, three large cap leaders are RBC's favorites now.
Endo International and BioDelivery Sciences have announced that the U.S. Food and Drug Administration (FDA) approved their long-term opioid treatment, Belbuca.
These biotech stocks 24/7 Wall St. has picked stood out from the rest with at least 25% gains over the course of the past week.
October 21, 2015: Here are four stocks trading with heavy volume among 94 equities making new 52-week lows today. Valeant Pharmaceuticals International Inc. (NYSE: VRX) dropped nearly 40% on...
24/7 Wall St. has collected several big FDA decisions coming up on the calendar for the month of October and added some color.
Tuesday's top analyst upgrades, downgrades and initiations include Ambarella, Apple, Bunge, McDonald's, Micron Technology and Occidental Petroleum.